Skin Cancer | Tumor

CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.

Melanoma Might Not Delay Family Planning

August 16th 2018

Researchers noted that melanoma diagnosis and treatment did not cause many women to put off becoming pregnant.

High Frequency of Common Skin Cancer May Warrant More Intensive Cancer Screening

August 15th 2018

Individuals diagnosed with a high frequency of basal cell carcinomas, a common type of skin cancer, may be at an increased for developing an unrelated cancer, highlighting the need for additional clinical screening.

Driving Research in Rare Cancers

August 7th 2018

Research continues to drive the oncology field.

Skin Effects from Type of Immunotherapy May Occur Even After Treatment Ends

August 7th 2018

Patients who receive anti-PD-1 therapies may experience delayed cutaneous side effects like lesions, eczema or psoriasis, even after treatment has ended.

Advances and Combinations Raise Sights on Uveal Melanoma

July 30th 2018

Clinical trials seek to discover new ways to attack the disease, limit metastasis and prevent recurrence.

When Cancer Clusters, Create a Medical Family Tree

July 28th 2018

Creating a medical family tree is helpful. If cancer is common, noting which branches include it can help inform decisions.

New Research Aim to 'Get Ahead' of Melanoma by Tracking Its Genetic Evolution

July 18th 2018

Understanding how melanoma spreads can lead to better outcomes. That's what researchers at UCSF aimed to do.

Be Sun Smart During UV Safety Awareness Month

July 13th 2018

July is UV Safety Awareness Month. See three tips on how to protect yourself from harmful UV rays, which are the leading cause of skin cancer.

Cancer Rates 'Soar' in Flight Crew Compared with General Population

July 4th 2018

While having a career as a flight attendant allows individuals to travel the globe, exposure to carcinogens and frequent disruptions in circadian rhythms may increase cancer prevalence in these individuals, according to recent research published in the journal Environmental Health.

FDA Approves Drug Duo for BRAF-Positive Melanoma

June 27th 2018

The FDA has approved the combination of the BRAF inhibitor Braftovi (encorafenib) and the MEK inhibitor Mektovi (binimetinib) for the treatment of patients with BRAF-mutant unresectable or metastatic melanoma, as detected by an FDA-approved test.

Keytruda Granted sBLA for Melanoma Treatment

June 25th 2018

The FDA has accepted a supplemental biologics license application (sBLA) for the use of Keytruda (pembrolizumab) as an adjuvant treatment for patients with resected, high-risk stage 3 melanoma, according to Merck (MSD), the manufacturer of the PD-1 inhibitor.

It Takes Two

June 22nd 2018

In melanoma, combining two immunotherapies may lower costs and improve quality of life.

New Therapies Are Gathering Speed

June 21st 2018

Novel immunotherapies either release the immune system’s parking brake or hit its gas pedal.

Contagious Enthusiasm

June 20th 2018

Oncolytic, or engineered, viruses that infect and kill cancer cells are showing promise.

The Jury Is Out

June 19th 2018

Checkpoint inhibitors can be extremely effective for the right patients, but identifying who will benefit remains an imprecise science.

Under New Management

June 19th 2018

A new expert guideline for managing immunotherapy’s side effects has been released.

Men Who Take Daily Aspirin at Higher Risk for Melanoma

June 15th 2018

Study findings published in the Journal of the American Academy of Dermatology showed that once-daily aspirin use can increase the risk of melanoma in men — nearly double that of men who do not use aspirin each day.

Testing Only the 'Tip of the Iceberg' for Common Hereditary Condition in MSI-H Tumors

June 14th 2018

Lynch syndrome – a hereditary condition that increases a person’s risk for developing several types of cancer – is common among people with microsatellite instability-high (MSI-H) tumors, linking it to several new cancer types, according to large genomic study results presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.

Immunotherapy Outcomes May Be Better in Older Patients With Melanoma

June 14th 2018

Age shouldn't be a determining factor in giving a patient with melanoma immunotherapy. In fact, one study found that older patients actually do better on checkpoint blockades.

Keep Hope: It's OK to Cry While Celebrating or Celebrate While Crying

June 11th 2018

Recognize birthdays, but most importantly, keep hope, says a breast cancer and melanoma survivor.

Larotrectinib Granted Priority Review for NTRK-Positive Cancers

May 29th 2018

The FDA has granted a priority review to a new drug application (NDA) for larotrectinib for the treatment of adult and pediatric patients with locally advanced or metastatic solid tumors with an NTRK gene fusion, according to Bayer and Loxo Oncology, the codevelopers of the pan-TRK inhibitor.

Patients and Caregivers Are on the 'Frontline' of Melanoma Monitoring

May 22nd 2018

Recent research, conducted at NYU Langone Health and presented at the Oncology Nursing Society (ONS) Annual Congress, sought to find out how patients with melanoma perceived skin health education, and their willingness be involved in their own surveillance or a loved one’s.

Skin Cancer Awareness Month from a Melanoma Survivor's Perspective

May 22nd 2018

One melanoma survivor offers advice for Skin Cancer Awareness Month.

Running, Stumbling and Finding the Way through Cancer

May 4th 2018

I think being an athlete is what saved my life.

The Melanoma Effect

May 4th 2018

If I ever got sick or injured I would go to the children’s hospital, but that was nothing like a real hospital where people are fighting for their life day-in and day-out. I absolutely hated it, and still do. I was in Emory Hospital visiting my dad two to three times a week for about six months, and every time I walked in that place, it just gave me the heebie-jeebies.

Your Cancer Game Plan

May 3rd 2018

Mike Schmidt developed stage 3 melanoma after years of playing professional baseball for the Philadelphia Phillies.

Dermatology Checkups After Breast Cancer

May 2nd 2018

After radiation, as the skin heals, a compassionate dermatologist can help us to monitor any lingering side-effects.

FDA Approves Combination for Adjuvant Treatment of Melanoma Subtypes

May 1st 2018

The combination therapy of Tafinlar (dabrafenib) and Mekinist (trametinib) was granted Food and Drug Administration (FDA) approval for the treatment of patients with BRAF V600E– or V600K–positive stage 3 melanoma following complete resection.

Spring Is Here, and So is Skin Cancer Awareness Month

April 30th 2018

May is skin cancer awareness month, and a good reminder to schedule an appointment with your dermatologist.

Older Patients with Metastatic Melanoma May Benefit from Immunotherapy

April 25th 2018

Age should not limit which patients with metastatic melanoma receive immunotherapy.